JBC Transcription and Nuclear Factor Monoclonals

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, G.-J.
Right arrow Articles by Wong, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, G.-J.
Right arrow Articles by Wong, C.-H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 49, 35139-35146, December 3, 1999


Expression of alpha 2,8/2,9-Polysialyltransferase from Escherichia coli K92
CHARACTERIZATION OF THE ENZYME AND ITS REACTION PRODUCTS*

Gwo-Jenn ShenDagger , Arun K. DattaDagger , Masayuki Izumi, Kathryn M. Koeller, and Chi-Huey Wong§

From the Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The capsular polysaccharide of Escherichia coli K92 contains alternating -8-NeuAcalpha 2- and -9-NeuAcalpha 2- linkages. The enzyme catalyzing this polymerizing reaction has been cloned from the genomic DNA of E. coli K92. The 1.2-kilobase polymerase chain reaction fragment was subcloned in pRSET vector and the protein was expressed in the BL21(DE3) strain of E. coli with a hexameric histidine at its N-terminal end. The enzyme was isolated in the supernatant after lysis of the cells and fractionated by ultracentrifugation. Western blotting using anti-histidine antibody showed the presence of a band that migrated at about 47.5 kDa on both reducing and nonreducing SDS-polyacrylamide gel electrophoresis, indicating a monomeric enzyme. Among the carbohydrate acceptors tested, N-acetylneuraminic acid and the gangliosides GD3 and GQ1b were preferred substrates. The cell-free enzyme reaction products obtained were characterized by NMR and mass spectrometry, which indicated the presence of both alpha 2,9- and alpha 2,8-linked polysialyl structure. The K92 neuS gene was used to transform the K1 strain of E. coli, the capsule of which contains only -8-NeuAcalpha 2- linkages. Analysis of the polysaccharides isolated from these transformed cells is consistent with the presence of both -8-NeuAcalpha 2- and -9-NeuAcalpha 2- linkages. Our results suggest that the neuS gene product of E. coli K92 catalyzes the synthesis of polysialic acid with alpha 2,9- and alpha 2,8-linkages in vitro and in vivo.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The 9-carbon 5-amino-3,5-dideoxy-D-glycero-D-galactononulosonic acids or sialic acids, comprise a family of neuraminic acid derivatives which are widely spread in nature, ranging from bacterial to human origin. This sugar moiety linked to carbohydrate chains of glycolipids and glycoproteins plays a key role in many important biological events mediated by carbohydrate-protein interactions (1). Sialic acids are also found in linear homopolymers (polysialic acid) of N-acetylneuraminic acid (NeuAc)1 and N-glycolylneuraminic acid (Neu5Gc) joined by alpha 2,8-, alpha 2,9-, or alpha 2,8/alpha 2,9-ketosidic linkages (2). The degree of polymerization can extend beyond 200 sialic acid residues (3), thereby constituting a structurally unique group of carbohydrate polymers which covalently modify cell-surface glycoconjugates (4). Polysialylation of the mammalian neural cell adhesion molecules, for example, affects the cell-cell adhesive interactions during embryogenesis, including neurite fasciculation and neuromuscular interactions (5, 6). While the neuroinvasive bacteria Escherichia coli K1 contain a homopolymer of -8-NeuAcalpha 2- (7), the Neisseria meningitidis Group C (8, 9) displays a homopolymer of -9-NeuAcalpha 2- linkages. On the other hand, the polysialic acid capsular antigens of neuroinvasive E. coli K92 are composed of poly(-8NeuAcalpha 2,9NeuAcalpha 2-) residues (10). Alternating linkages of alpha 2,8NeuAc- and alpha 2,9NeuAc- could not be found in mammalian systems, and therefore could be utilized to elicit immunological response. In fact, the heteropolymer from K92 strain of E. coli is being imployed as a carbohydrate vaccine in the clinical trial of patients suffering from acute meningitidis (11).

The sialyltransferases that catalyze the addition of sialic acid to form such diverse carbohydrate recognition molecules fall into at least two families. While 13 clones have been obtained from mammalian systems (12), only 4 have been cloned from bacterial systems to date (13-16). Recent cloning of both mammalian and bacterial sialyltransferases showed that these two gene families evolved differently. The polysialyltransferase encoded by neuS in E. coli uses CMP-sialic acid as a donor and catalyzes a sequential addition of sialic acid to the nonreducing end of an acceptor (3, 17, 18). In a detailed study using the pathogenic strain of E. coli K1, the gene coding for CMP-Neu5Ac:poly-alpha 2,8-sialosyl sialyltransferase, termed neuS, has been cloned. This gene was found to be clustered in the kps region which is implicated in the initiation, polymerization, and possibly translocation of polysialic acid chains across the inner membrane (13, 19, 20). A similar gene has been identified by hybridization to the K92 strain of E. coli, the capsule of which contains poly(-8NeuAcalpha 2,9NeuAcalpha 2-) (10). The complete nucleotide sequence of this K92 neuS gene showed that this gene product differs by 70 amino acids from the K1 neuS gene product (14). Although an in vitro study indicated that the neuS from E. coli K1 coding for a 47-kDa protein has polysialyltransferase activity, no such activity has yet been clearly demonstrated for the neuS product from E. coli K92. In this study, we have cloned the neuS gene from the K92 strain of E. coli by PCR using the primers described previously (14), expressed the gene in E. coli, and shown that the enzyme from this gene catalyzes the synthesis of polysialic acids with both alpha 2,8- and alpha 2,9-linkages in vitro and in vivo.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cloning of K92 neuS Gene-- The genomic DNA isolated from E. coli strain K92 (ATCC 35860) using a DNA extraction kit (Qiagen Co., Valencia, CA) was used for the amplification of the neuS gene by PCR. This was performed in a 100-µl reaction mixture containing 100 ng of genomic DNA as template, 300 nmol of primers, 200 mM dNTPs, 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgCl2, 0.01% gelatin, 0.1% Triton X-100, and a mixture of both Taq DNA polymerase and pfu DNA polymerase (1 unit of each). Two primers, the forward primer with internal BamHI (underlined) site (5'-ATATTGGATCC)ATATTTGATGCTAGTTTA-3'; nucleotides 3-20) and a reverse primer with EcoRI site, (5'-GGCGCGAATTCTTACTCCCCCAAGAAAA-3'; nucleotides 1230-1214) designed based on the previously published sequence (14) were used for PCR using the following conditions: 94 °C, 1 min; 50 °C, 1 min; and 72 °C, 2 min for 35 cycles. Agarose gel analysis of the product showed the presence of one major band with the expected size of about 1.2 kilobases. The fragment obtained was purified by agarose gel electrophoresis, digested with BamHI and EcoRI, and subcloned into a similarly digested pRSET vector (Invitrogen Co., San Diego, CA) following standard molecular biological techniques (21). The ligation mixture was then used for transformation of competent cells of the BL21(DE3) strain of E. coli (Novagen, Madison, WI). The clone containing the expression vector was confirmed by sequencing of both strands using an automated DNA sequencer (ABI 377) at the TSRI Core facility.

Expression of the K92 neuS Gene-- Since the DH5alpha strain of E. coli lacking the kps gene cluster does not have sialyltransferase activity (18), it was used initially to express the gene. This strain has a pilli forming gene in its chromosome and therefore does not require any pressure for the expression of its sex pilli. M13 phage containing the T7 RNA polymerase gene (Invitrogen) was used to infect DH5alpha F' transformed with pRSET vector containing the cloned neuS gene. The transformed cells were grown in LB medium (with 1 mM MgCl2) containing 100 µg of carbicillin/ml at 37 °C to A600 ~0.3 and then 1 mM IPTG was added. After 1 h of incubation, the M13/T7 phage was added to infect the cells as described by the supplier (Invitrogen), and harvested after 5 h of incubation. An enzyme activity assay and SDS-PAGE of the cell lysate (15 K supernatant) showed expression of the neuS gene in DH5alpha F'. A band migrating as ~47.5 kDa in the 12% SDS-PAGE appeared within 1 h of incubation after infection with the T7 RNA polymerase gene containing M13 in the presence of IPTG (as judged by Western blot). The relative intensity of the 47.5-kDa band increased with time and reached maximum after 4 h. Enzymatic assay of the cell-free extract using sialic acid as acceptor also indicated the expression of the K92 polysialyltransferase. However, the DH5alpha F' cells transformed with pRSET vector also yielded a band comigrating with the 47.5-kDa band in SDS-PAGE. Attempts to separate these bands using Ni2+-NTA-agarose proved to be difficult. We therefore decided to express this protein in the HMS174(DE3)Lys or BL21(DE3) strain of E. coli (Invitrogen).

The transformed BL21(DE3) cells containing the neuS gene from the K92 strain of E. coli were grown exponentially in LB medium (with 1 mM MgCl2) containing 100 µg of carbicillin/ml at 37 °C until A600 ~ 0.3 was reached. Expression of the neuS gene was achieved at 37 °C by induction with IPTG as described in the expression kit (Invitrogen, Carlsbad, CA). The cells were harvested after 5 h of incubation.

Western Blot-- This analysis was done by following a standard technique (22). The protein samples were boiled for 8-10 min in 1× Laemmli gel sample buffer either in the absence or presence of 10% beta -mercaptoethanol. Electrophoresis was performed using 10% SDS-polyacrylamide gel in Tris/glycine SDS buffer. After the proteins were transferred to a nitrocellulose membrane, the blot was blocked with a blocking buffer (blotto in TBS and 0.1% Tween 20) and developed by adsorption with the mouse anti-(His)5 monoclonal antibody (Qiagen, Valencia, CA) diluted (1:500) with the blocking buffer. The blot was incubated with horseradish peroxidase-conjugated sheep anti-mouse secondary antibody (1:1000; Amersham Pharmacia Biotech). The protein bands were visualized either by chemiluminescence as suggested by the supplier of the reagents (Amersham Pharmacia Biotech) or by staining with the immunoPure Metal Enhanced DAB Substrate Kit (Pierce, Rockford, IL).

Sialyltransferase Assay-- The assay was carried out essentially as described by Vimr and co-workers (23) with the following modifications: after harvesting, the cells were washed three times with 25 mM Tris-HCl (pH 8.0) and then resuspended in 25 mM Tris-HCl (pH 8.0) containing 5 mM MgCl2, 5 mM dithiothreitol (DTT), and 1 µl/ml protease inhibitor mixture (Sigma). Cells were lysed three times by using a French Press (Aminco; 1,500 p.s.i.). The cell debris was removed by centrifugation twice at 15,000 rpm and the supernatant was collected (termed the 15 K Sup). This supernatant was then centrifuged again at 100,000 × g (~40,000 rpm) using a Beckman ultracentrifuge (Model L5-50). Both the supernatant (termed the 40 K Sup) and the pellet were saved. The pellet was resuspended in a buffer containing 25 mM Tris-HCl, 5 mM MgCl2, 5 mM DTT, and 0.1% Triton CF-54. The supernatants and the pellet were stored on ice, and used for assay within 2 h.

Without the addition of acceptor, the endogenous enzyme activity was determined. The exogenous activity was then detected by addition of sialic acid as acceptor and CMP-[14C]NeuAc as donor in a reaction buffer containing 25 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 5 mM DTT, and 0.5% Triton CF-54. Other substrates were also used, including colominic acid. Both the endogenous and exogenous enzyme activity assays measure the transfer of 14C-labeled NeuAc to the acceptor. Unreacted radiolabeled substrates were separated by DEAE-cellulose TLC (1-propanol, 14 M NH4OH/H2O, 6:1:3) or by Sephadex G-25 column chromatography. Radioactivity remaining at the origin and/or at the top of the TLC plate or the product obtained at the void volume of Sephadex G-25 column, was quantitated by liquid scintillation spectrometry. For analysis using Sephadex G-25 column chromatography, a column (1 × 3.5 cm) of Sephadex G-25 (Amersham Pharmacia Biotech) in water was prepared. The radiolabeled cell-free reaction mixture (60 µl) was loaded and washed with 1.5 ml of water, which was collected and counted. In some experiments, the activity was determined by separating the unused CMP-[14C]NeuAc by Dowex 1X8 (phosphate form) column chromatography (24). The initial rates were estimated graphically, and activity was expressed as picomoles of sialic acid transferred per hour.

Thin-layer Chromatography and Fluorography-- After the cell-free reaction was complete, the proteins were removed by an Amicon filter (MWCO 10 K), and the supernatant containing oligomeric reaction products was separated by Silica Gel 60 (aluminum backed) and/or DEAE-cellulose (plastic backed) thin-layer chromatography (TLC) using the following solvent systems: (a) 1-propanol, 14 M NH4OH, H2O, 6:1:3; (b) chloroform, methanol, 0.02% CaCl2, 30:55:15. Control chromatograms were calibrated with mono- to hexasialosyl oligomers (Calbiochem, San Diego, CA) which were detected by orcinol spray, as described by Corfield and Schauer (25). This method resolved monomeric through octameric sialic acids. Oligomers composed of nine or more sialosyl residues were retained at the origin. Labeled chromatograms were sprayed with En3Hance (NEN Life Science Products Inc.) and fluorographed against an intensifier screen. After fluorography, sialosyl oligomers were detected on Silica Gel 60 TLC plates by orcinol spray for alignment of radioactive signals with colorimetrically detected bands. For analysis using DEAE-cellulose TLC, the position of the cell-free 14C-labeled reaction product(s) was marked after alignment of radioactive signals, cut and counted.

Isolation and Purification of Polysialylated Oligosaccharides-- Strains of E. coli transformed with vector only or with the K92 neuS gene were used for the extraction of polysaccharide following the method of Kasper et al. (26) with the following modifications. For K92 polysaccharide, the K92 strain of E. coli was grown in 2 liters of Davis' supplemental minimal medium (ATCC media formulation number 54) at 37 °C overnight. The K1 strain of E. coli transformed with the K92 neuS gene was grown in 2 liters of Davis' supplemental minimal medium containing 2% glycerol instead of glucose. The cells were grown to A600 ~ 0.3 and 1 mM IPTG (final concentration) was added. After incubation at 37 °C for 1 h, M13/T7 phages (Invitrogen; 10 plaque forming units/cell) were added and incubated at 37 °C. After overnight growth the organisms were removed by centrifugation (48,000 × g for 30 min at 4 °C), and the supernatant was collected and filtered through a 0.45-µm Millipore filter. Hexadecyltrimethyl ammonium bromide (Cetavlon, 0.3%; Sigma) was added to the supernatant with stirring and the precipitate formed was collected by centrifugation. The precipitate was solubilized in 0.9 M CaCl2 and reprecipitated with 3 volumes of chilled (-20 °C) absolute ethanol. The ethanol precipitation from 0.9 M CaCl2 was repeated three times. The final product was dialyzed against water and lyophilized. The final purification was done using a column (2 × 25 cm) of Bio-Gel P-2 (Amersham Pharmacia Biotech) eluted with water following the usual procedure, and verified by polyacrylamide gel electrophoresis following the method of Troy and McCloskey (7). After hydrolysis by sulfuric acid (0.1 N H2SO4, 80 °C), quantitation of sialic acid was determined by the thiobarbituric acid procedure as described previously (27).

Protein Assay-- This was done using bicinconic acid (BCA) reagent following the instructions provided by the supplier (Pierce).

Mass Spectrometry Analysis-- The electrospray ionization (ES-MS) mass spectrometry experiments were performed on an API III Perkin-Elmer SCIEX triple quadrupole mass spectrometer. Electrospray samples were typically introduced to the mass analyzer at a rate of 4.0 ml/min. The positive and negative ions, generated by charged droplet evaporation, enter the analyzer through an interface plate and a 100-mm orifice, while the declustering potential is maintained between 50 and 200 V to control the collisional energy of the ions entering the mass analyzer. The emitter voltage is typically maintained at 5000 V. The m/z was determined for the major peaks.

NMR Analysis-- 13C nuclear magnetic resonance spectra were recorded at about 23 °C on a Bruker AMX-400 or DRX-600 spectrometer operating in the pulsed Fourier transform mode using broad band proton noise decoupling. The polysaccharides were run as deuterium oxide solutions at pH 7.0. The solvent, D2O, served as an internal lock signal. dimethyl sulfoxide was often used as internal reference. The 13C spectrum of polysaccharides from K1 and K92 determined in this study were found to be identical to that presented by Egan et al. (10). The K1 polysaccharide NHCO (amide carbonyl) resonances from the present and Egan's studies were taken to have the same chemical shift and all remaining signals referenced accordingly.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cloning of the neuS Gene from K92-- Previously, the neuS gene from the K1 strain of E. coli was cloned and found to have the alpha 2,8-polysialyltransferase activity. Using the K1 neuS gene as a probe, Vimr et al. (14) cloned a 1230-base pair gene (14) from the K92 strain of E. coli that had 87.3% homology to the K1 gene. The deduced protein sequence from this gene indicated the same number of amino acids (total 409 amino acids) with 83% homology to that of K1 at the protein level. Previous structural studies on the polysaccharide antigen of this E. coli K92 strain (Bos-12) suggested the presence of polysialic acid with alternating alpha 2,8- and alpha 2,9-linkages (10). Therefore, the gene product from the K92 strain is assumed to confer polysialyltransferase activity (14, 23). However, expression of the neuS gene from K92 was not clearly demonstrated, nor was it shown to form a polymer of sialic acid in vitro with alternating alpha 2,8/2,9-linkages.

To characterize the K92 neuS gene product, we have cloned this gene from the E. coli K92 strain using a PCR based approach. The primers were designed based on the previously published sequence (14), and used to amplify the full-length clone of the neuS gene from the genomic DNA of the K92 strain. The 1.23-kilobase fragment obtained by PCR was subcloned in pRSET (Invitrogen) for expression of the neuS gene product as a fusion protein with the hexameric histidine tag fused at its N-terminal end (Fig. 1). The clone was verified by double-strand sequencing of the entire fragment including the restriction sites.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Construction of the expression vector for the K92 neuS expression as a fusion protein. The PCR fragment, 91.2 kilobases, obtained for the full-length form of the K92 neuS gene using its genomic DNA as template, was subcloned in pRSET vector (Novagen, Madison, WI) using two unique restriction sites, BamHI and EcoRI. This resulted in the expression of the protein with a hexameric histidine tag fused at its N-terminal end. The vector provides the start codon followed by the sequence for the hexameric histidine. The full-length form of the protein remains mostly as membrane bound form. However, about 30-40% of the protein is "released" in the 40 K Sup upon treatment with a detergent. This released protein retains full catalytic activity and was used in this study.

A hydrophilicity plot (28, 29) revealed two potential membrane-spanning regions in this protein of 409 amino acid residues. The first one is located 177 residues from the N terminus. It consists of 19 hydrophobic amino acids bordered by three upstream lysine residues. Interestingly, this first transmembrane domain is bordered on either end by a proline residue. Proline is known to confer conformational constraints of many biologically important proteins, as evidenced by site-directed mutagenesis studies (see Ref. 30, for a review, see Ref. 31). A similar KKKP motif, found to be present in the ST6Gal I (for nomenclature, see Ref. 12) polypeptide, is part of a proposed signal anchor sequence (32). The second transmembrane domain is located 327 residues from the N terminus. It consists of 17 hydrophobic amino acid residues bordered by two upstream lysine residues and a proline residue at its C terminus. Notably, lysine and serine are predominantly present in this domain. The presence of these two transmembrane domains suggests that this protein is membrane-bound as further supported by the Western blot (see below). This feature appears to be unique among the cloned bacterial sialyltransferases, the hydrophilicity plot of which suggests the presence of only one potential membrane-spanning region.

Expression of the K92 neuS Gene-- For expression, we used pRSET (Invitrogen), a prokaryotic expression vector designed to obtain a hexameric histidine tag fused at the N-terminal sequence of the desired protein. Due to the lack of any antibody available against the K92 neuS gene product, the polysialyltransferase was expressed as a fusion protein, and detected by the Western blot using anti-(His)5 antibody (Qiagen Inc., Valencia, CA).

SDS-Polyacrylamide Gel Electrophoresis and Western Blot-- The cell-free crude extract (15 K Sup and 40 K Sup) and the cell pellet, suspended in 25 mM Tris-HCl (pH 8.0) containing 5 mM MgCl2 and 0.1% Triton CF-54, obtained by ultracentrifugation were analyzed by SDS-PAGE. Coomassie Blue staining showed the presence of various bands including a major band at about 47.5 kDa, the expected size for the neuS gene product. This band was absent in the control (cells transformed with pRSET vector only). Replica gel was used to transfer the proteins to a nitrocellulose membrane and detected by using mouse monoclonal anti-(His)5 antibody (Qiagen, Valencia, CA). The blot was finally developed by using Enhanced DAB substrates following the protocol of the supplier (Pierce) or by a chemiluminescence technique as described earlier (30). The Western blot clearly showed the presence of a single band at about 47.5 kDa (Fig. 2). The alpha 2,8/2,9-polysialyltransferase was also found to be present in the 40,000 supernatant. Our initial attempt to purify the protein using Ni2+-NTA-agarose column failed. Although the fusion protein apparently binds to the Ni2+-NTA-agarose, nonspecific binding with other cellular proteins was also observed. Therefore, the 40 K Sup was used in this study for enzyme assay and analysis of its product(s).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot analysis of the K92 neuS expressed protein. E. coli cells of BL21(DE3) transformed with K92 neuS gene in the expression vector pRSET were induced with IPTG (1 mM final concentration) and harvested after 4 h. Cells transformed with pRSET vector only were also grown and used as negative control. As a positive control, BL21(DE3) previously transformed with the histidine-tagged thioesterase gene subcloned in pET20B(+) were grown, induced, and harvested similarly. After harvesting, the cells were lysed and the supernatants were collected after centrifugation at 15,000 rpm (15 K Sup). The proteins were run using a 12% SDS-PAGE as mentioned under "Materials and Methods." The samples were: 15 K Sup from the negative control (lane 1), 15 K Sup from the cells transformed with K92 neuS gene (lane 2), and 15 K Sup from the positive control (lane 3). The blot was developed using anti-(His)5 antibody (Qiagen) and metal enhanced DAB substrate kit (Pierce). The neuS expressed alpha 2,8/2,9-polysialyltransferase migrated in the gel at about 47.5 kDa. In lane 3, the positive control for the Western blot showed a band at ~23 kDa for the thioesterase. It may be noted that the expression level for the neuS gene was comparatively lower than the thioesterase gene.

Sialyltransferase Assay-- The cell-free crude extract (15 K Sup), 40 K supernatant (40 K Sup), and the pellet were used for the assay of various acceptor substrates and CMP-[14C]NeuAc as donor substrate. The activity could be traced in all these fractions. After the reaction was over, the products were analyzed by TLC or Sephadex G-25 column chromatography. Fig. 3 shows a representative analysis. Using cold sialic acid as acceptor and CMP-[14C]NeuAc as donor, a major spot was detected on TLC using various solvent systems. Interestingly, this new spot behaved as non-polar material on DEAE-cellulose TLC (Fig. 3C). It was found that sialic acid served as a good acceptor, whereas colominic acid did not (Table I). 9-O-Acetylsialic acid was not well accepted, indicating that polymerization probably starts at the C-9 position of the sialic acid acceptor. Notably, pentameric and hexameric polysialosides with alpha 2,8-linkages were not accepted, whereas the corresponding dimer and trimer (Calbiochem) served as poor acceptors. Among the glycolipids tested, GD3 and GQ1b also served as good acceptors. However, other sialylgangliosides tested were poor substrates (Table I).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 3.   Analysis of the enzyme reaction products by thin-layer chromatography (TLC). The 40 K Sup was used as a source of the enzyme in the reaction mixture containing 1 mM acceptor and CMP-[14C]NeuAc (9 nmol; 1 µCi) as donor in a reaction buffer containing 25 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 5 mM DTT, and 0.5% Triton CF-54. As an example, analysis was shown with the reaction mixture containing sialic acid and GM3 as acceptors and CMP-[14C]NeuAc as donor substrate. As a negative control, the reaction mixture contained sialic acid as acceptor without the addition of any enzyme. For A and B, Silica Gel 60 TLC plates were used for the samples: reaction mixture without the enzyme (lane 1), GM3 as acceptor (lane 2), sialic acid as acceptor (lane 3), and reaction mixture without exogenous sialic acid (lane 4). The solvents used were: (a) 1-propanol, 1 M NH4OH, water; 7:1:2; (b) chloroform, methanol, 0.02% CaCl2; 45:55:10. The reaction mixtures were also analyzed by DEAE-cellulose TLC. After the reaction was complete, a part of the sample was acidified with 10% acetic acid and incubated for 30 min at room temperature. For C, DEAE-cellulose TLC plate was used. The samples were: reaction mixture with sialic acid as acceptor (lane 1) and after acidification (lane 2); reaction mixture without enzyme (lane 3) and after acidification (lane 4); using GM3 as acceptor (lane 5) and after acidification (lane 6); reaction mixture without exogenous acceptor (lane 7) and after acidification (lane 8). The solvents in C used were: 1-propanol, 14.5 M NH4OH, water; 6:1:3. The plates were dried after the run and exposed to Kodak XAR-5 film. The arrow indicates the position of the potential cell-free reaction product(s). The position of CMP-NeuAc and free sialic acid were also shown. We found that both the enzyme and its reaction products are unstable and degrade over time.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Substrate specificity of the neuS gene product of E. coli K92 expressed in BL21(DE3)
The reaction mixture (60 µl) contained 1 µM each of the following acceptors and 9 nmol of CMP-[14C]NeuAc (specific activity: 8000 cpm/nmol) as donor substrate. The reactions were carried out at 37 °C for 1 h using 20 µg of 40 K Sup as mentioned under "Materials and Methods." The reaction mixture (1 µl) was spotted on a plastic backed DEAE-cellulose TLC plate, and ran in 1-propanol, 14.5 M NH4OH; water, 6:1:3. After air drying, the plate was exposed to Kodak XAR-5 film for overnight at -70 °C. The area corresponding to the reaction product was marked, cut and then counted in scintillation fluid.

Structural Determination of the Cell-free Reaction Product-- For structural determination, the cell-free reactions were carried out, using the 40,000 supernatant as the enzyme source, with sialic acid and unlabeled CMP-NeuAc in a molar ratio of 1:10 to obtain the reaction product(s) in a sufficient quantity. Since it was known that the by-product CMP inhibits the forward reaction, alkaline phosphatase was added to remove CMP in order to increase the yield. As mentioned above, the product moved as a non-polar material on DEAE-cellulose TLC, a characteristic utilized for purification of the cell-free reaction product(s). After the reaction was complete, the reaction mixture was passed through a column of Dowex 1X8 (phosphate form) to remove unreacted CMP-NeuAc and sialic acid. The negative ion mass spectral analysis (ES-MS) showed (Fig. 4) a major peak at m/z 1419 for (M-3H2O-H+)- and at m/z 1401 for (M-4 H2- H). This spectrum was similar to that of the commercially obtained alpha 2,8-polysialic acid (pentamer; Calbiochem). While the authentic sample showed a fragmentation pattern accounting for the tetramer (m/z at 1182 for M-3H2O-H+)-, trimer (m/z at 890 for M-3H2O-H+)-, dimer (m/z at 599 for M-3H2O-H+)-, and monomer (m/z at 308 for M-3H2O-H+)- fragments (see Fig. 4A), the fragmentation pattern for the reaction product was slightly different, probably due to the presence of alternating alpha 2,8- and alpha 2,9-linkages in the cell-free reaction product(s). The degree of polymerization appears to be limited by the concentration of CMP-NeuAc. The production of a pentamer as the major product in the cell-free reaction is probably due to the limitation of CMP-NeuAc concentration along with the limited degree of polymerization. Increasing the amount of CMP-NeuAc in the cell-free reaction indeed increases the chain length of the sialyl polymer as judged by mass spectrometry (Fig. 5). While the MALDI-MS (Core Facility, The Scripps Research Institute) of the commercially available pentamer (Calbiochem) showed a peak for m/z at 1473, a peak at m/z 1474 was obtained with 10 mM CMP-NeuAc and at m/z 3830 with 20-30 mM CMP-NeuAc.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Mass-spectral analysis of the enzyme reaction product. For the mass spectral analysis, the cell-free reaction was carried out using 40 K Sup. The reaction mixture contained 1 mM sialic acid and 10 mM CMP-NeuAc as donor in a reaction buffer containing 25 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 5 mM DTT, 0.5% Triton CF-54. To drive the forward reaction, the liberated CMP was removed by the addition of alkaline phosphatase (1 units). After the reaction was over, the reaction material was passed through an Amicon filter (10 MWCO) and the filtrate was used for analysis. The cell-free enzyme reaction product behaved similar to the pentameric sialic acid (Calbiochem), on TLC. in various solvent systems. Mass spectra were compared with that of commercially available pentameric sialic acid. Negative ion mass spectrum (ES-MS) of: A, standard pentameric polysialic acid; and B, cell-free reaction product. The major peaks for m/z were marked by an arrow and described in the text. The molecular ion (M - H+)- was also shown. Some minor products with higher mass (m/z) were also observed.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 5.   Mass spectral analysis of the enzyme reaction products with increasing concentration of CMP-NeuAc. The cell-free enzyme reactions were performed as described in the legend to Fig. 4 with 1 mM sialic acid and increasing concentration of CMP-NeuAc (10, 15, 20, and 30 mM). After the reaction was complete, the materials were filtered (Amicon; 10 MWCO) and the filtrate from each reaction tube was directly used for mass-spectrometry (MALDI-MS). The spectra were: A, standard pentamer (Calbiochem); B, reaction product using 10 mM CMP-NeuAc; and C, reaction product using 20 mM CMP-NeuAc. The major peaks for m/z were shown by the arrow and described in the text. A similar spectrum (as C) was observed using 30 mM CMP-NeuAc.

The E. coli strain K1 which forms the homopolymer of alpha 2,8-linked sialic acids in its capsule was transformed with the neuS gene from K92. This was done to investigate whether the K92 neuS gene product competes with the endogenous alpha 2,8-polysialyltransferase for the same endogenous acceptor in vivo. The capsular polysaccharide from the transformed K1 was isolated and purified by Bio-Gel P-2 column chromatography as mentioned under "Materials and Methods." 13C NMR of this polysaccharide in D2O showed a spectrum different from that of the K1- and K92-derived polysialic acids (Fig. 6). The major peaks for the NCOCH3 and NCOCH3 were similar to those of both K1 and K92. However, the signal for C-2 at delta 103.44 was comparatively weaker. This may be due to the complex nature of the polysaccharide from transformed cells. Moreover, the 13C NMR spectra obtained for the transformed K1 was similar to that of the polymer obtained from the K92 strain of E. coli, which also showed two closely adjacent signals at delta  23.36 and 23.51. It was shown earlier that this particular strain of E. coli contains heteropolysialyl oligosaccharide with alternating alpha 2,8/2,9-linkages (10). This complexity was also evident in the 1H NMR spectrum (Fig. 7) which showed two peaks at delta 1.99 and delta 1.96. While a detailed structural study is in progress, the preliminary data indicates that the polysaccharide isolated from the transformed K1 has both alpha 2,8- and alpha 2,9-linkages present in random sequences. This suggests that not only is the K92 neuS gene functional in the K1 strain of E. coli, but also that its expression disrupted normal polysialyl chain elongation. This result is probably due to the competition for the same endogenous acceptor in vivo. It also suggests that the endogenous acceptor is neither sialic acid nor colominic acid, but is common for both the alpha 2,8- and alpha 2,8/2,9-polysialyltransferases.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   13C NMR analysis of the capsular polysaccharide. The spectra were recorded on a Brucker DRX-600 spectrometer. The scale is in parts per million and relative to external dimethyl sulfoxide. The spectra of the purified capsular polysaccharies were from K1 (A), K1 transformed with K92neuS (B), and K92 (C). The numbering of the carbon atoms is based on the previously published results (10).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 7.   1H NMR analysis of the capsular polysaccharide of K1 transformed with K92/neuS. The spectra were recorded on a Brucker DRX-600 at an ambient temperature. Only the region for amide methyl groups from alpha 2,8- and alpha 2,9-linkages of the purified capsular polysaccharide have been shown for comparison. The isolation and purification of the capsular polysaccharides were described under "Materials and Methods." The spectra of the capsular polysaccharides were from K1 (A), K92 (B), and K1 transformed with K92/neuS (C). While the K1 sample showed only a singlet at delta 1.99, K92 showed two peaks at delta 2.00 and delta 1.96. The spectrum obtained from the transformed K1 was broad and complex, especially at ~delta 1.99.

Interestingly, the cell-free enzyme reaction product(s) appears to be prone to lactone formation. As shown in Fig. 3, The radiolabeled product ran as a non-polar sialoside on DEAE-cellulose TLC and also passed through a column of Dowex 1X8 (phosphate form). Lactone formation appears to depend on sample preparation conditions, and seems to be preferable at lower pH. This lactonization was also observed at pH 8.0, presumably because the pH of the reaction mixture decreased during the reaction. The electrospray mass analysis also suggested lactone formation of cell-free reaction product(s). The peak for m/z at 1401 is consistent with the loss of four H2O to form 4 lactones (Fig. 4) and the major peak for m/z at 1419 is consistent with the formation of 3 lactones from the pentameric product. Additional supporting evidence for the presence of lactones is the 13C peaks at ~97 ppm, (Fig. 8), which are also observed in the authentic pentamer lactone prepared from the partial hydrolysis of the K92 polysaccharide. These peaks shift to ~103.5 ppm when lactone hydrolysis under basic conditions is performed. Based on the recent observation of regioselective lactonization of alpha 2,8-linked oligomeric sialic acid (33, 34), the carboxyl group of the nonreducing end sialic acid may exist as an open form (Fig. 9).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 8.   13C NMR analysis of the enzyme reaction product. After the enzyme reaction, the protein was removed by filtration (Amicon; 10,000). The enzyme reaction product was separated from unreacted sialic acid and CMP-NeuAc by passing through a column of Dowex 1X8 (PO4- form) eluting with phosphate buffer. The product was collected in the void volume and desalted by passing through a small column of Sephadex G-50 eluting with water. The desired material was collected in the void volume, freeze-dried, and dissolved in D2O for NMR analysis. The spectra were recorded on a Brucker DRX-600 spectrometer at an ambient temperature (20 °C). The scale is in parts per million and relative to external dimethyl sulfoxide. Spectrum A, commercially available alpha 2,8-linked pentameric sialic acid used as standard, results from approximately 25,000 accumulations. Spectrum B, partially purified cell-free reaction product, results from approximately 40,000 accumulations.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 9.   Proposed structure of the cell-free reaction product. The product obtained by the cell-free reaction using K92 neuS protein, indicated the structure of a pentameric sialic acid with alternating alpha 2,9/2,8-linkages (I). The proposed major lactone form (II) obtained in the enzymatic reaction is also shown.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

While sialic acid is ubiquitous in eukaryotes, particularly in mammals (12), it is not detected in prokaryotes other than some pathogenic bacteria. These include some E. coli strains, some N. meningitidis strains and bacteria of the O serotype including Salmonella (35-37). Although the presence of polysialyltransferase activity in E. coli was reported earlier by Roseman et al. (17), the nature of the gene and its product was not clearly demonstrated until recently. The cloned neuS gene from K1 showed that its product has similar size but no sequence homology to any of the mammalian sialyltransferases. Expression of the K1 neuS gene indicates that this 47-kDa protein synthesizes polysialic acid in vitro (13). A similar gene was cloned from the K92 strain of E. coli, the capsule of which was shown to contain heteropolysialic acid (-8NeuAcalpha 2, 9NeuAcalpha 2-) (10). This gene product differs by 70 amino acids when compared with that of the neuS gene product of the K1 strain (14). Of the observed amino acid replacements, 36 were conservative. On the basis of such homology, it was postulated that the K92 gene evolved from neuS of K1 (14). By complementation assay, the K92 neuS gene was shown by this group (23) to express polysialyltransferase activity yielding a product that was recognized by meningitidis C antiserum in vivo, suggesting that this gene might produce sialoside with alternating alpha 2,8/2,9-polysialyl linkages. However, because meningitidis C antiserum interacts with both homopolysialic acid (-9-NeuAcalpha 2-) from N. meningitidis Group C and heteropolysialic acid (-8Neu Acalpha 2,9NeuAcalpha 2-) from the K92 strain of E. coli (38), structural identification of the cell-free reaction product(s) was warranted. Previously, the expression of the K92 neuS gene was not clearly demonstrated, nor was it shown that this gene product catalyzes the synthesis of heteropolysialic acid (-8NeuAcalpha 2,9NeuAcalpha 2-) in vitro.

The polysialyltransferase encoded by neuS in E. coli uses CMP-sialic acid as a donor and catalyzes sequential sialylation at the 9-position of the nonreducing end of appropriate acceptors. Using K1 neuS, the polymerase activity was detected in vitro with sialyloligomers (designated colominic acid) or with certain gangliosides, such as GD3 (13) as substrates. However, it was shown previously that this gene product could not initiate de novo polysialic acid synthesis (23), indicating a requirement for an as yet undefined in vivo primer. This primer, or polymerization initiator, does not appear to be colominic acid, since this polymer was neither elongated efficiently in vitro (18) nor the elongated product detected in vivo (39). Using K92 neuS, we have found that colominic acid is not an acceptor. In fact, among the acceptors tested, only sialic acid and certain gangliosides were found to be good acceptors. The real substrate specificity, however, remains to be investigated using the purified enzyme.

In conclusion, this report describes for the first time that the neuS gene product from E. coli K92 exhibits alpha 2,8/2,9-polysialyltransferase activity both in vitro and in vivo. Apparently a single polypeptide (as judged by the Western blot) for this polysialyltransferase catalyzes the synthesis of polysialic acid with alternating alpha 2,9- and alpha 2,8-linkages. Previously, bacterial KDO-transferase was shown to possess such dual linkage specificity (40). Thus, enzymes capable of forming multiple different linkages may not be uncommon in nature. A recent report on the study of a crude preparation of polysialyltransferase from K92 indicates that the enzyme recognizes an alpha 2,8-glycosidic linkage of sialic acid at the nonreducing end (41), consistent with our finding. It also indicates that the alpha 2,9-linked homopolysialic acid or the alpha 2,8/alpha 2,9-linked heteropolymer of sialic acid with alpha 2,9-linkage at the nonreducing end is not acceptable (41), and the enzyme may catalyze the sequential transfer of a preformed alpha 2,8-linked dimer to the 9-position of the acceptor, a novel mechanism which remains to be proven. Work is in progress to purify the enzyme and to define the substrate specificity and mechanism.

    FOOTNOTES

* The work was supported in part by the National Institutes of Health Grant GM44154 (to C. H. W.). This paper was presented at the 19th International Carbohydrate Symposium, August 9, 1998, San Diego.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Contributed equally to this work.

§ To whom correspondence should be addressed: Dept. of Chemistry, BCC 338, The Scripps Research Institute, 10550 N. Torrey Pines Rd., San Diego, CA 92037. Tel: 858-784-2487; Fax: 858-784-2409; E-mail: wong@scripps.edu.

    ABBREVIATIONS

The abbreviations used are: NeuAc, neuraminic acid; PCR, polymerase chain reaction; CMP-NeuAc, CMP-neuraminic acid or CMP-sialic acid; IPTG, isopropyl-1-thio-beta -D-galactopyranoside; PAGE, polyacrylamide gel electrophoresis; DTT, dithiothreitol; ES-MS, electrospray mass spectrometry; GM3, NeuAcalpha 2,3Galbeta 1,4Glcbeta -ceramide; GD3, NeuAcalpha 2,8NeuAcalpha 2,3Galbeta 1,4Galbeta -ceramide; GQ1b, NueAcalpha 2,8 NeuAcalpha 2,3Galbeta 1,3GalNAcbeta 1,4(NueAcalpha 2,8Neualpha 2,3)Galbeta 1,4Glcbeta -ceramide; GD2, GalNAcbeta 1,4(NeuAcalpha 2,8NeuAcalpha 2,3)Galbeta 1,4Glcbeta -ceramide; GT1a, NueAcalpha 2,3Galbeta 1,3(NeuAcalpha 2,6)GalNAcbeta 1,4(Neu Acalpha 2,3)Galbeta 1,4Glcalpha -ceramide; GT1b, NeuAcalpha 2,3Galbeta 1,3GalNAcbeta 1,4 (NeuAcalpha 2,8 NeuAcalpha 2,3)Galbeta 1,4Glcbeta -ceramide.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Schauer, R., Kelm, S., Reuter, G., Roggentin, P., and Shaw, L. (1995) in Biology of the Sialic Acids (Rosenberg, A., ed) , pp. 7-67, Plenum Press, New York
2. Troy, F. A. (1992) Glycobiology 2, 5-23[Free Full Text]
3. Rohr, T. E., and Troy, F. A. (1980) J. Biol. Chem. 255, 2332-2342[Abstract/Free Full Text]
4. Troy, F. A. (1990) Trends Glycosci. Glycotechnol. 2, 430-449
5. Edelman, G. M. (1985) Cold Spring Harbor Symp. Quant. Biol. 50, 877-889[Medline] [Order article via Infotrieve]
6. Cunningham, B. A., Hemperly, J. J., Murray, B. A., Prediger, E. A., Brackenbury, R., and Edelman, G. M. (1987) Science 236, 799-806[Abstract/Free Full Text]
7. Troy, F. A., and McCloskey, M. A. (1979) J. Biol. Chem. 254, 7377-7387[Abstract/Free Full Text]
8. Liu, T.-Y., Gotschlich, E. C., Donne, F. T., and Jonssen, E. K. (1971) J. Biol. Chem. 246, 4703-4712[Abstract/Free Full Text]
9. Vann, W. F., Liu, T.-Y., and Robbins, J. B. (1978) J. Bacteriol. 133, 1300-1306[Abstract/Free Full Text]
10. Egan, W., Liu, T.-Y., Dorow, D., Cohen, J. S., Robbins, J. D., Gotschlich, E. C., and Robbins, J. B. (1977) Biochemistry 16, 3687-3692[CrossRef][Medline] [Order article via Infotrieve]
11. Devi, S. J., Robbins, J. B., and Schneerson, R. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7175-7179[Abstract/Free Full Text]
12. Tsuji, S., Datta, A. K., and Paulson, J. C. (1996) Glycobiology 6, v-vii
13. Weisgerber, C., Hansen, A., and Frosch, M. (1991) Glycobiology 1, 357-365[Abstract/Free Full Text]
14. Vimr, E. R., Bergstrom, R., Steenbergen, S. M., Boulnois, G., and Roberts, I. (1992) J. Bacteriol 174, 5127-5131[Abstract/Free Full Text]
15. Gilbert, M., Cunningham, A.-M., Watson, D. C., Martin, A., Richards, J. C., and Wakarchuk, W. W. (1997) Eur. J. Biochem. 249, 187-194[Medline] [Order article via Infotrieve]
16. Yamamoto, T., Nakashizuka, M., and Terada, I. (1998) J. Biochem. (Tokyo) 123, 94-100[Abstract/Free Full Text]
17. Kundig, F. D., Aminoff, D., and Roseman, S. (1971) J. Biol. Chem. 246, 2543-2550[Abstract/Free Full Text]
18. Steenbergen, S. M., and Vimr, E. R. (1990) Mol. Microbiol. 4, 603-611[Medline] [Order article via Infotrieve]
19. Weisgerber, C., and Troy, F. A. (1990) J. Biol. Chem. 265, 1578-1587[Abstract/Free Full Text]
20. Steenbergen, S. M., and Vimr, E. R. (1991) Glycoconjug. J. 8, 145
21. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
22. Harlow, E., and Lane, D. (1988) Antibodies , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
23. Steenbergen, S. M., Wrona, T. J., and Vimr, E. R. (1992) J. Bacteriol. 174, 1099-1108[Abstract/Free Full Text]
24. Williams, M. A., Kitagawa, H., Datta, A. K., Paulson, J. C., and Jamieson, J. C. (1995) Glycoconj. J. 12, 755-761[CrossRef][Medline] [Order article via Infotrieve]
25. Corfield, A. P., and Schauer, R. (1982) Cell Biol. Monogr. 10, 77-94
26. Kasper, D. L., Winkelhake, J. L., Zollinger, W. D., Brandt, B., and Artenstein, M. S. (1973) J. Immunol. 110, 262-268[Abstract/Free Full Text]
27. Liu, J. L-C., Shen, G-J., Ichikawa, Y., Rutan, J. F., Zapata, G., Vann, W. F., and Wong, C-H. (1992) J. Am. Chem. Soc. 114, 3901-3910[CrossRef]
28. Hopp, T. P., and Woods, K. R. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 3824-3828[Abstract/Free Full Text]
29. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105-132[CrossRef][Medline] [Order article via Infotrieve]
30. Datta, A. K., Sinha, A., and Paulson, J. C. (1998) J. Biol. Chem. 273, 9608-9614[Abstract/Free Full Text]
31. Vanhoop, G., Goossens, F., De Meester, I., Hendricks, D., and Scharpe, S. (1995) FASEB J. 9, 736-744[Abstract]
32. Weinstein, J., Lee, E. U., McEntee, K., Lai, P.-H., and Paulson, J. C. (1987) J. Biol. Chem. 262, 17735-17743[Abstract/Free Full Text]
33. Cheng, M.-C., Lin, C.-H., Khoo, K.-H., and Wu, S.-H. (1999) Angew. Chem. Int. Ed. Engl. 38, 686-689[CrossRef]
34. Zhang, Y., and Lee, Y. C. (1999) J. Biol. Chem. 274, 6183-6189[Abstract/Free Full Text]
35. Barry, G. T. (1965) Bull. Soc. Chim. Biol. 47, 529-533.34
36. Barry, G. T., Abbot, V., and Tsai, T. (1962) J. Gen. Microbiol. 29, 335-352
37. Glode, M. P., Robbins, J. B., Liu, T-Y., Gotschlich, E. C., Orskov, I., and Orskov, F. (1977) J. Infect. Dis. 135, 94-102[Medline] [Order article via Infotrieve]
38. Pelkonen, S. (1990) Curr. Microbiol. 21, 23-28
39. Clementz, T., and Raetz, C. R. H. (1991) J. Biol. Chem. 266, 9687-9696[Abstract/Free Full Text]
40. Lee, Y-L., Chen, J. C., and Shaw, J-F. (1997) Biochem. Biophys. Res. Commun. 231, 452-456[CrossRef][Medline] [Order article via Infotrieve]
41. Chao, C.-F., Chuang, H.-C., Chiou, S.-T., and Liu, T.-Y (1999) J. Biol. Chem. 274, 18206-18212[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
L. M Willis, M. Gilbert, M.-F. Karwaski, M.-C. Blanchard, and W. W Wakarchuk
Characterization of the {alpha}-2,8-polysialyltransferase from Neisseria meningitidis with synthetic acceptors, and the development of a self-priming polysialyltransferase fusion enzyme
Glycobiology, February 1, 2008; 18(2): 177 - 186.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
H. Tsukamoto, Y. Takakura, T. Mine, and T. Yamamoto
Photobacterium sp. JT-ISH-224 Produces Two Sialyltransferases, {alpha}-/{beta}-Galactoside {alpha}2,3-Sialyltransferase and {beta}-Galactoside {alpha}2,6-Sialyltransferase
J. Biochem., February 1, 2008; 143(2): 187 - 197.
[Abstract] [Full Text] [PDF]